Filing Details
- Accession Number:
- 0001367644-21-000144
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-15 17:53:15
- Reporting Period:
- 2021-11-15
- Accepted Time:
- 2021-11-15 17:53:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1196632 | S Richard Lindahl | 400 Professional Drive, Suite 400 Gaithersburg MD 20879 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-15 | 3,000 | $37.46 | 39,919 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $37.32 to $37.63.
Billionaire Hedge Funds
